|
Volumn 35, Issue 7, 2011, Pages 968-970
|
Polymorphisms in integrin genes and lymphoma risk
|
Author keywords
Innate immunity; Integrin; Lymphoma; Single nucleotide polymorphism
|
Indexed keywords
ADAM19 PROTEIN;
INTEGRIN;
INTERCELLULAR ADHESION MOLECULE 3;
PROTEIN PTGDR;
UNCLASSIFIED DRUG;
ADAM19 GENE;
ADULT;
AGED;
ARTICLE;
CANCER RISK;
CHRONIC LYMPHATIC LEUKEMIA;
CONTROLLED STUDY;
FEMALE;
FOLLICULAR LYMPHOMA;
GENETIC ASSOCIATION;
GENETIC RISK;
GENETIC VARIABILITY;
HUMAN;
ICAM3 GENE;
LARGE CELL LYMPHOMA;
LYMPHOCYTOMA;
MAJOR CLINICAL STUDY;
MARGINAL ZONE LYMPHOMA;
NONHODGKIN LYMPHOMA;
POPULATION BASED CASE CONTROL STUDY;
PRIORITY JOURNAL;
PTGDR GENE;
RISK REDUCTION;
SINGLE NUCLEOTIDE POLYMORPHISM;
T CELL LYMPHOMA;
UNITED STATES;
ADAM PROTEINS;
AGED;
ANTIGENS, CD;
CASE-CONTROL STUDIES;
CELL ADHESION MOLECULES;
CONNECTICUT;
FEMALE;
GENOTYPE;
HUMANS;
LYMPHOMA, NON-HODGKIN;
MALE;
MIDDLE AGED;
POLYMORPHISM, SINGLE NUCLEOTIDE;
RECEPTORS, IMMUNOLOGIC;
RECEPTORS, PROSTAGLANDIN;
RISK FACTORS;
|
EID: 79958739572
PISSN: 01452126
EISSN: 18735835
Source Type: Journal
DOI: 10.1016/j.leukres.2010.12.012 Document Type: Article |
Times cited : (5)
|
References (8)
|